Cargando…

Adipokines as Biomarkers of Atopic Dermatitis in Adults

Atopic dermatitis (AD) is characterized by chronic, relapsing, pruritic skin inflammation and does not have a well-understood pathogenesis. In this study, we addressed the contribution of adipokines to AD eczema based on the assessment of blood levels of adiponectin, resistin, leptin, lipocalin-2, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaworek, Andrzej Kazimierz, Szepietowski, Jacek C., Szafraniec, Krystyna, Jaworek, Magdalena, Hałubiec, Przemysław, Wojas-Pelc, Anna, Pokorski, Mieczysław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565141/
https://www.ncbi.nlm.nih.gov/pubmed/32899610
http://dx.doi.org/10.3390/jcm9092858
_version_ 1783595870189518848
author Jaworek, Andrzej Kazimierz
Szepietowski, Jacek C.
Szafraniec, Krystyna
Jaworek, Magdalena
Hałubiec, Przemysław
Wojas-Pelc, Anna
Pokorski, Mieczysław
author_facet Jaworek, Andrzej Kazimierz
Szepietowski, Jacek C.
Szafraniec, Krystyna
Jaworek, Magdalena
Hałubiec, Przemysław
Wojas-Pelc, Anna
Pokorski, Mieczysław
author_sort Jaworek, Andrzej Kazimierz
collection PubMed
description Atopic dermatitis (AD) is characterized by chronic, relapsing, pruritic skin inflammation and does not have a well-understood pathogenesis. In this study, we addressed the contribution of adipokines to AD eczema based on the assessment of blood levels of adiponectin, resistin, leptin, lipocalin-2, and vaspin in adult non-obese patients suffering from chronic extrinsic childhood-onset AD. We investigated 49 AD patients with a median age of 37 years. The control group consisted of 30 age-matched healthy subjects. Adipokines were assessed in the serum by ELISA assays and the severity of AD with the SCORing Atopic Dermatitis (SCORAD) index. We found that adiponectin and resistin decreased and leptin appreciably increased in AD patients when compared to those in healthy subjects. Further, the levels of adiponectin and resistin were inversely related to the intensity of eczema. In conclusion, apart from the formerly investigated role of leptin in AD, this study points to adiponectin and resistin as the potential candidate adipokine biomarkers involved in shaping eczema intensity and severity, which may help predict disease exacerbations and enable the development of effective targeted therapeutic interventions.
format Online
Article
Text
id pubmed-7565141
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75651412020-10-26 Adipokines as Biomarkers of Atopic Dermatitis in Adults Jaworek, Andrzej Kazimierz Szepietowski, Jacek C. Szafraniec, Krystyna Jaworek, Magdalena Hałubiec, Przemysław Wojas-Pelc, Anna Pokorski, Mieczysław J Clin Med Article Atopic dermatitis (AD) is characterized by chronic, relapsing, pruritic skin inflammation and does not have a well-understood pathogenesis. In this study, we addressed the contribution of adipokines to AD eczema based on the assessment of blood levels of adiponectin, resistin, leptin, lipocalin-2, and vaspin in adult non-obese patients suffering from chronic extrinsic childhood-onset AD. We investigated 49 AD patients with a median age of 37 years. The control group consisted of 30 age-matched healthy subjects. Adipokines were assessed in the serum by ELISA assays and the severity of AD with the SCORing Atopic Dermatitis (SCORAD) index. We found that adiponectin and resistin decreased and leptin appreciably increased in AD patients when compared to those in healthy subjects. Further, the levels of adiponectin and resistin were inversely related to the intensity of eczema. In conclusion, apart from the formerly investigated role of leptin in AD, this study points to adiponectin and resistin as the potential candidate adipokine biomarkers involved in shaping eczema intensity and severity, which may help predict disease exacerbations and enable the development of effective targeted therapeutic interventions. MDPI 2020-09-04 /pmc/articles/PMC7565141/ /pubmed/32899610 http://dx.doi.org/10.3390/jcm9092858 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jaworek, Andrzej Kazimierz
Szepietowski, Jacek C.
Szafraniec, Krystyna
Jaworek, Magdalena
Hałubiec, Przemysław
Wojas-Pelc, Anna
Pokorski, Mieczysław
Adipokines as Biomarkers of Atopic Dermatitis in Adults
title Adipokines as Biomarkers of Atopic Dermatitis in Adults
title_full Adipokines as Biomarkers of Atopic Dermatitis in Adults
title_fullStr Adipokines as Biomarkers of Atopic Dermatitis in Adults
title_full_unstemmed Adipokines as Biomarkers of Atopic Dermatitis in Adults
title_short Adipokines as Biomarkers of Atopic Dermatitis in Adults
title_sort adipokines as biomarkers of atopic dermatitis in adults
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565141/
https://www.ncbi.nlm.nih.gov/pubmed/32899610
http://dx.doi.org/10.3390/jcm9092858
work_keys_str_mv AT jaworekandrzejkazimierz adipokinesasbiomarkersofatopicdermatitisinadults
AT szepietowskijacekc adipokinesasbiomarkersofatopicdermatitisinadults
AT szafranieckrystyna adipokinesasbiomarkersofatopicdermatitisinadults
AT jaworekmagdalena adipokinesasbiomarkersofatopicdermatitisinadults
AT hałubiecprzemysław adipokinesasbiomarkersofatopicdermatitisinadults
AT wojaspelcanna adipokinesasbiomarkersofatopicdermatitisinadults
AT pokorskimieczysław adipokinesasbiomarkersofatopicdermatitisinadults